IndraLab

Statements


| 1

reach
"Encouragingly, the combination of ursolic acid and oxaliplatin remarkably inhibited p-ERK1/2, p-Akt, and p-IKKalpha, which was much more significant compared to those treated with ursolic acid or oxaliplatin alone."